Enteris BioPharma is dedicated to building long-term, strategic relationships and offers our partners a robust formulation strategy that begins with in-vitro characterization of their compound and goes through manufacturing tablet formulations that provide fully optimized GMP clinical trial material. Key capabilities include:
- Development and execution of a robust formulation strategy
- Pre-formulation and formulation screening
- Pre-clinical studies
- Tablet formulation optimization
- Analytical optimization & validation
- Fully optimized GMP clinical trial material manufacturing
- Release and stability testing
Interested in Becoming a Partner?
Contact us today to learn how you can partner with Enteris BioPharma
and become part of the solution.